Infections associated with solid tumors

  • Sarah H. Sutton
  • John P. Flaherty
Part of the Cancer Treatment and Research book series (CTAR)


According to American Cancer Society estimates, leukemias and lymphomas accounted for only 7% of male and 6% of female cancers diagnosed and 8% of cancer deaths; the remaining cancers were solid tumors [1]. Although solid tumors account for the vast majority of cancer in adults, severe infectious complications in these patients are far less common than in patients with hematologic malignancies. For instance, Elting et al. [2] reported that polymicrobial sepsis was 16 times less common per patient admission in patients with solid tumors than patients with acute leukemia. Similarly, Mayo and Wenzel [3] found that nosocomial bloodstream infections were 15 times less likely in solid tumor patients than leukemia patients. Nevertheless, patients with solid tumors complicated by infection are not unusual. We reviewed the last 100 cancer patients seen by our infectious disease inpatient consultation service and the majority (62) had underlying solid tumors (J. P. Flaherty, unpublished observation). Common scenarios included wound infection, pneumonia, intravascular catheter-related sepsis, and fever and neutropenia following intensive chemotherapy.


Lung Cancer Patient Axillary Lymph Node Dissection Tuberculin Skin Test Septic Arthritis Liver Abscess 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boring CC, Squires TS, Tong T, Montgomery S. Cancer Statistics, 1994. CA Cancer J Clin 1994;44:7–26.PubMedGoogle Scholar
  2. 2.
    Elting LS, Bodey GP, Fainstein V. Polymicrobial septicemia in the cancer patient. Medicine 1986;65:218–225.PubMedCrossRefGoogle Scholar
  3. 3.
    Mayo JW, Wenzel RP. Rates of hospital-acquired bloodstream infections in patients with specific malignancy. Cancer 1982:50:187–190.PubMedCrossRefGoogle Scholar
  4. 4.
    Mathe G, Meyer P, Brienza S. Gil-Delgado M, Orbach-Arbouys S, Itzhaki M. Retrospective study correlating clinical infectious history and peripheral blood T-cell subpopulations in cancer, GvH and HIV+ patients. Biomed Pharmacother 1992;46:17–19.PubMedCrossRefGoogle Scholar
  5. 5.
    Pizzo PA, Robichaud KJ, Wesley R, Commers JR. Fever in the pediatric and young adult patient with cancer: A prospective study of 1001 episodes. Medicine 1982;61:153–165.PubMedCrossRefGoogle Scholar
  6. 6.
    Singer C, Kaplan MH, Armstrong D. Bacteremia and fungemia complicating neoplastic disease: A study of 364 cases. Am J Med 1977:62:731–742.PubMedCrossRefGoogle Scholar
  7. 7.
    Krumpe PE, Knudson RJ, Parsons G, Reiser K. The aging respiratory system. Clin Geriatr Med 1985:1:143–175.PubMedGoogle Scholar
  8. 8.
    Brugarolas A, Takita H. Immunologic status in lung cancer. Chest 1973;64:427–430.PubMedCrossRefGoogle Scholar
  9. 9.
    Busch E, Verazin G, Antkowiak JG, Driscoll D, Takita H. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest 1994;105:760–766.PubMedCrossRefGoogle Scholar
  10. 10.
    Kohno S, Koga H, Oka M, Kadota J, Kaku M, Soda H, Tomono K, Hara K. The pattern of respiratory infection in patients with lung cancer. Tohoku J Exp Med 1994; 173:405–411.PubMedGoogle Scholar
  11. 11.
    Strang C, Simpson JA. Carcinomatous abscess of the lung. Thorax 1953;8:11–28.PubMedGoogle Scholar
  12. 12.
    Perlman LV, Lerner E, D’Esopo N. Clinical classification and analysis of 97 cases of lung abscess. Am Rev Respir Dis 1969;99:390–398.PubMedGoogle Scholar
  13. 13.
    Snider GL, Saleh SS. Empyema of the thorax in adults: Review of 105 cases. Dis Chest 1968:54:12–11.Google Scholar
  14. 14.
    Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med 1976;136:67–70.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease: A review of 201 cases. Cancer 1974;33:850–858.PubMedCrossRefGoogle Scholar
  16. 16.
    Snider GL, Placik B. The relationship between pulmonary tuberculosis and bronchogenic carcinoma: A topographic study. Am Rev Resp Dis 1969:99:229–236.PubMedGoogle Scholar
  17. 17.
    Nagata N, Nikaido Y, Kido M, Ishibashi T, Sueishi K. Terminal pulmonary infections in patients with lung cancer. Chest 1993;103:1739–1742.PubMedCrossRefGoogle Scholar
  18. 18.
    Smith FB, Bveneck B. Localized aspergillus infestation in primary lung carcinoma: Clinical and pathological contrasts with post-tuberculous intracavitary aspergilloma. Chest 1991; 100:554–556.PubMedCrossRefGoogle Scholar
  19. 19.
    De Vuyst P, De Troyer A, Yernault J, Verhest A, Vanderhoeft P. Aspergilloma in a necrotic bronchial adenocarcinoma. Eur J Respir Dis 1980;61:213–217.PubMedGoogle Scholar
  20. 20.
    Meyer RD, Young LS, Armstrong D, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973;54:6–15.PubMedCrossRefGoogle Scholar
  21. 21.
    Borkin MH, Arena FP, Brown AE, Armstrong D. Invasive aspergillosis with massive fatal hemoptysis in patients with neoplastic disease. Chest 1980;78:835–839.PubMedCrossRefGoogle Scholar
  22. 22.
    Smith JM, Hampton JR, Webb RW. Disseminated aspergillosis, Cushing’s syndrome, and oat cell carcinoma of the lung. Chest 1979:76:112–113.PubMedCrossRefGoogle Scholar
  23. 23.
    Sidransky H, Friedman L. The effect of cortisone and antibiotic agent on experimental pulmonary aspergillosis. Am J Pathol 1959:35:169–183.PubMedGoogle Scholar
  24. 24.
    Hasan FM, Jarrah T, Nassar V. The association of adenocarcinoma of the lung and blastomycosis from an unusual geographical location. Br J Dis Chest 1978:72:242–246.PubMedCrossRefGoogle Scholar
  25. 25.
    Blastomycosis Cooperative Study of the Veterans Administration: A review of 198 collected cases in Veterans Administration hospitals. Am Rev Resp Dis 1964;89:659–672.Google Scholar
  26. 26.
    Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP. Primary Candida pneumonia: Experience at a large cancer center and review of the literature. Medicine 1993:72:137–142.PubMedGoogle Scholar
  27. 27.
    Yale SH. Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illnesses and prior corticosteroid therapy. Mayo Clinic Proc 1996;71:5–13.Google Scholar
  28. 28.
    Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992;267:832–837.PubMedCrossRefGoogle Scholar
  29. 29.
    Graham BS, Tucker WS. Opportunistic infections in endogenous Cushing’s syndrome. Ann Intern Med 1984;101:334–338.PubMedGoogle Scholar
  30. 30.
    Frenkel JK, Good JT, Shultz JA. Latent Pneumocystis infection in rats, relapse, and chemotherapy. Lab Invest 1966;15:1559–1577.PubMedGoogle Scholar
  31. 31.
    Walzer PD, LaBine M, Redington TJ, Cushion MT. Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: Relation to Pneumocystis carinii pneumonia. J Immunol 1984:133:2502–2508.PubMedGoogle Scholar
  32. 32.
    Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AOS. Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 1991;48:406–409.PubMedGoogle Scholar
  33. 33.
    Poplin EA, Gordon CJ, Piskorowski TJ, Chandrasekar PH. Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndrome. Cancer 1991;68:193–194.PubMedCrossRefGoogle Scholar
  34. 34.
    Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, Lane HC, Urmacher C, Honig C, Longo DL, Parker MM, Natanson C, Parrillo JE, Fauci AS, Pizzo PA, Masur H. Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984:100:663–671.PubMedGoogle Scholar
  35. 35.
    Limper AH, Offord KP, Smith TF, Martin WJ. Pneumocystis carinii pneumonia: Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204–1209.PubMedGoogle Scholar
  36. 36.
    Sepkowitz KA. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: Who should receive prophylaxis? Mayo Clin Proc 1996;71:102–103.PubMedGoogle Scholar
  37. 37.
    Camazine B, Antkowiak JG, Nava MER, Lipman BJ, Takita H. Herpes simplex viral pneumonia in the postthoracotomy patient. Chest 1995;108:876–879.PubMedGoogle Scholar
  38. 38.
    Coggle JE, Lambert BE, Moores SR. Radiation effects in the lung. Environ Health Perspect 1986;70:261–291.PubMedCrossRefGoogle Scholar
  39. 39.
    Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977;86:81–92.PubMedGoogle Scholar
  40. 40.
    Mclnerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin. Br J Radiol 1977;50:224–227.PubMedCrossRefGoogle Scholar
  41. 41.
    Schwarz MI, Whitcomb ME, Goldman AL. The spectrum of diffuse pulmonary infiltration in malignant disease. Chest 1973;64:88–93.PubMedCrossRefGoogle Scholar
  42. 42.
    Pisani RJ, Wright AJ. Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc 1992;67:221–227.PubMedGoogle Scholar
  43. 43.
    Shure D. Transbronchial biopsy and needle aspiration. Chest 1989;95:1130–1138.PubMedCrossRefGoogle Scholar
  44. 44.
    Rotstein C, Ferguson R, Cummings KM, Piedmonte MR, Lucey J, Banish A. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect Control Hosp Epidemiol 1992;13:207–214.PubMedCrossRefGoogle Scholar
  45. 45.
    Sauter ER, Eisenberg BL, Hoffman JP, Ottery FD, Boraas MC, Goldstein LJ, Solin LJ. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Surg 1993;17:237–242.PubMedCrossRefGoogle Scholar
  46. 46.
    Vinton AL, Traverso LW, Jolly PC. Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg 1991;161:584–588.PubMedCrossRefGoogle Scholar
  47. 47.
    Mozes M, Papa MZ, Karasik A, Reshef A, Adar R. The role of infection in post-mastectomy lymphedema. Surg Ann 1982;14:73–83.Google Scholar
  48. 48.
    Bertelli G, Venturini M, Forno G, Macchiavello F, Dini D. An analysis of prognostic factors in response to conservative treatment of postmastectomy lymphedema. Surg Gynecol Obstet 1992;175:455–460.PubMedGoogle Scholar
  49. 49.
    Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992;93:543–548.PubMedCrossRefGoogle Scholar
  50. 50.
    Chaudhuri K, Lonergan D, Portek I, McGuigan L. Septic arthritis of the shoulder after mastectomy and radiotherapy for breast carcinoma. J Bone Joint Surg Br 1993;75-B:318–321.Google Scholar
  51. 51.
    Rescigno J, McCormick B, Brown AE, Myskowski PL. Breast cellulitis after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1994;29:163–168.PubMedGoogle Scholar
  52. 52.
    Olivotto IA, Weir L, Kim-Sing C. In response to Rescigno et al. Int J Radiat Oncol Biol Phys 1995;31:203.PubMedCrossRefGoogle Scholar
  53. 53.
    Keidan RD, Hoffman JP, Weese JL, Hanks GE, Solin LJ, Eisenbe BL, Ottery FD, Borass M. Delayed breast abscesses after lumpectomy and radiation therapy. Am Surg 1990;56:440–444.PubMedGoogle Scholar
  54. 54.
    Mudad R, Vredenburgh J, Paulson EK, Ross M, Meisenberg B, Hussein A, Peters WP. A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. Cancer 1994;74:1360–1366.PubMedCrossRefGoogle Scholar
  55. 55.
    Parry BR. Radiation recall induced by tamoxifen. Lancet 1992;340:49.PubMedCrossRefGoogle Scholar
  56. 56.
    Rostom, AY, ME El-Sayed. Fat necrosis of the breast: An unusual complication of lumpectomy and radiotherapy in breast cancer. Clin Radiol 1987;38:31.PubMedCrossRefGoogle Scholar
  57. 57.
    Bertelli G, Dini D, Forno GG, Gozza A. Preventing cellulitis after axillary lymph node dissection. Am J Med 1994;97:202–203.PubMedCrossRefGoogle Scholar
  58. 58.
    Dixon JM. Breast infection. Br Med J 1994;309:946–949.Google Scholar
  59. 59.
    Finegold SM. Anaerobic bacteria: General concepts. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone, 1995, pp. 2156–2173.Google Scholar
  60. 60.
    Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977;297:800–802.PubMedCrossRefGoogle Scholar
  61. 61.
    Klein RS, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 1979;91:560–562.PubMedGoogle Scholar
  62. 62.
    Fass R, Alim A, Kaunitz JD. Adenocarcinoma of the colon presenting as Streptococcus sanguis bacteremia. Am J Gastroenterol 1995;90:1343–1345.PubMedGoogle Scholar
  63. 63.
    Wiseman A, Rene P, Crelinsten GL. Streptococcus agalactiae endocarditis: An association with villous adenomas of the large intestine. Ann Intern Med 1985;103:893–894.PubMedGoogle Scholar
  64. 64.
    Gelfand MS, Hughey JR, Sloas DD. Group B Streptococcal bacteremia associated with adenocarcinoma of the stomach. Clin Infect Dis 1994;19:364.PubMedGoogle Scholar
  65. 65.
    Katlic MR, Derkac WM, Coleman WS. Clostridium septicum infection and malignancy. Ann Surg 1981;193:361–364.PubMedCrossRefGoogle Scholar
  66. 66.
    Koransky JR, Stargel MD, Dowell VR. Clostridium septicum bacteremia: Its clinical significance. Am J Med 1979;66:63–66.PubMedCrossRefGoogle Scholar
  67. 67.
    Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy: Report of 2 cases and review of the literature. Medicine 1989;68:30–37.PubMedCrossRefGoogle Scholar
  68. 68.
    Gorbach SL, Thadepalli H. Isolation of Clostridium in human infections: Evaluation of 114 cases. J Infect 1975;131:S81–S85.Google Scholar
  69. 69.
    Jendrzejewski JW, Jones SR, Newcombe RL, Gilbert DN. Nontraumatic clostridial myonecrosis. Am J Med 1978;65:542–546.PubMedCrossRefGoogle Scholar
  70. 70.
    Kaiser CW, Milgrom ML, Lynch JA. Distant nontraumatic clostridial myonecrosis and malignancy. Cancer 1986;57:885–889.PubMedCrossRefGoogle Scholar
  71. 71.
    Hovenden JL, Murdoch GE, Evans AT. Non-traumatic Clostridium septicum arthritis in a patient with caecal carcinoma. Br J Rheumatol 1992;31:571–572.PubMedCrossRefGoogle Scholar
  72. 72.
    Fallon SM, Guzik HJ, Kramer JE. Clostridium septicum arthritis associated with colonic carcinoma. J Rheumatol 1986;13:662–663.PubMedGoogle Scholar
  73. 73.
    Alpern RJ, Dowell VR. Clostridium septicum infections and malignancy. JAMA 1969; 209:385–388.PubMedCrossRefGoogle Scholar
  74. 74.
    Kahn SP, Lindenauer SM, Wojtalik RS, Hildreth D. Clostridia hepatic abscess: An unusual manifestation of metastatic colon carcinoma. Arch Surg 1972;104:209–212.PubMedGoogle Scholar
  75. 75.
    Kudsk KA. Occult gastrointestinal malignancies producing metastatic Clostridium septicum infections in diabetic patients. Surgery 1992;112:765–772.PubMedGoogle Scholar
  76. 76.
    Cohen JL, Martin M, Rossi RL, Schoetz DJ. Liver abscess: The need for complete gastrointestinal evaluation. Arch Surg 1989;124:561–564.PubMedGoogle Scholar
  77. 77.
    Marcus SG, Walsh TJ, Pizzo PA, Danforth DN. Hepatic abscess in cancer patients: Characterization and management. Arch Surg 1993;128:1358–1364.PubMedGoogle Scholar
  78. 78.
    Okada S, Aoki K, Okazaki N, Nose H, Yoshimori M, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamaski S, Takayasu K, Moriyama N. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report. Hepatogastroenterology 1993;40:496–498.Google Scholar
  79. 79.
    Isobe H, Sakamoto S, Nawata H. Splenic abscess as a complication of percutaneous ethanol injection therapy for hepatocellular carcinoma. J Clin Gastroenterol 1992;15:167–169.PubMedCrossRefGoogle Scholar
  80. 80.
    Teitz S, Guidetti-Sharon A, Manor H, Halevy A. Pyogenic liver abscess: Warning indication of silent colonic cancer: Report of a case and review of the literature. Dis Colon Rectum 1995;38:1220–1223.PubMedCrossRefGoogle Scholar
  81. 81.
    Lonardo A, Grisendi A, Pulvirenti M, Delia Casa G, Melini L, DiGregorio C, Nasi G, Sarti M, Tamborrino E, Lonardo F. Right colon adenocarcinoma presenting as Bacteroides fragilis liver abscesses. J Clin Gastroenterol 1992;14:335–338.PubMedCrossRefGoogle Scholar
  82. 82.
    Wolfe MS, Armstrong D, Louria DB, Blevins A. Salmonellosis in patients with neoplastic disease: A review of 100 epidsodes at Memorial Cancer Center over a 13-year period. Arch Intern Med 1971;128:546–554.PubMedCrossRefGoogle Scholar
  83. 83.
    Han T, Sokal JE, Neter E. Salmonellosis in disseminated malignant diseases: A seven-year review (1959–1965). N Engl J Med 1967;276:1045–1052.PubMedCrossRefGoogle Scholar
  84. 84.
    Kate P, Osei K, Chiemchanya S, Zatuchni J. Empyema due to Salmonella typhimurium with underlying alveolar cell carcinoma. South Med J 1984;77:234–236.PubMedGoogle Scholar
  85. 85.
    Berkeley D, Mangels J. Salmonella pneumonia in a patient with carcinoma of the lung. Am J Clin Pathol 1980:74:476–478.PubMedGoogle Scholar
  86. 86.
    Brooker DC, Savage JE, Twiggs LB, Adcock LL, Prem KA, Sanders CC, Infectious morbidity in gynecologic cancer. Am J Obstet Gynecol 1987;156:513–520.PubMedGoogle Scholar
  87. 87.
    Welton JA. Significance of infection in carcinoma of the cervix. Obstet Gynecol 1965;26:441–446.Google Scholar
  88. 88.
    Rose PG, Wilson G. Advanced cervical carcinoma presenting with toxic shock syndrome. Gynecol Oncol 1994:52:264–266.PubMedCrossRefGoogle Scholar
  89. 89.
    Barton DPJ, Fiorica JV, Hoffman MS, Roberts WS, Finan MA, Cavanagh D. Cervical cancer and tuboovarian abscesses: A report of three cases. J Reprod Med 1993;38:561–564.PubMedGoogle Scholar
  90. 90.
    Imachi M, Tanaka S, Ishikawa S, Matsuo K. Spontaneous perforation of pyometra presenting as generalized peritonitis in a patient with cervical cancer. Gynecol Oncol 1993;50:384–388.PubMedCrossRefGoogle Scholar
  91. 91.
    DeVoe RW, Randall LM. Pyometra: A clinical and pathologic study. Am J Obstet Gynecol 1949:58:784–789.PubMedGoogle Scholar
  92. 92.
    Douvier S, Nabholtz J-M, Friedman S, Cougard P, Ferry C, Aupecle P. Infectious pneumoperitoneum as an uncommon presentation of endometrial carcinoma: Report of two cases. Gynecol Oncol 1989:33:392–394.PubMedCrossRefGoogle Scholar
  93. 93.
    Andriessen MPHM, Mulder JG. Sleijfer DT. Lactobacillus septicemia, an unusual complication during the treatment of metastatic choriocarcinoma. Gynecol Oncol 1991:40:87–89.PubMedCrossRefGoogle Scholar
  94. 94.
    Connor JP, Buller RE. Lactobacillus sepsis with pelvic abscess. Gynecol Oncol 1994:54:99–100.PubMedCrossRefGoogle Scholar
  95. 95.
    Graham JE. Infectious morbidity in gynecologic oncology. J Reprod Med 1990;35:348–352.PubMedGoogle Scholar
  96. 96.
    Van Nagell JR, Parker JC, Maruyama Y, Utley J, Hager WD, Donaldson ES, Wood EG. The effect of pelvic inflammatory disease on enteric complications following radiation therapy for cervical cancer. Am J Obstet Gynecol 1977:128:767–771.PubMedGoogle Scholar
  97. 97.
    Lamm DL, van der Meijden PM, A Morales A, Brosman SA. Catalona WJ, Herr HW, Soloway MS, Steg A, Debruyne FM. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596–600.PubMedGoogle Scholar
  98. 98.
    Proctor DD, Chopra S, Rubenstein SC, Jokela JA, Uhl L. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guérin installation for bladder carcinoma. Am J Gastroenterol 1993:88:1112–1115.PubMedGoogle Scholar
  99. 99.
    Hakim S, Heaney JA, Heinz T. Zwolak RW. Psoas abscess following intravesical bacillus Calmette-Guérin for bladder cancer: A case report. J Urol 1993:150:188–189.PubMedGoogle Scholar
  100. 100.
    Katz DS, Wogalter H, D’Esposito RF, Cunha BA. Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma. Urology 1992:40:63–66.PubMedCrossRefGoogle Scholar
  101. 101.
    Chazerain P, Desplaces N, Mamoudy P, Leonard P, Ziza J. Prosthetic total knee infection with a bacillus Calmette Guérin (BCG) strain after BCG therapy for bladder cancer. J Rheumatol 1993:20:2171–2172.PubMedGoogle Scholar
  102. 102.
    Van Thiel RJ, Nossent GD, Tjonpiangi NP. Articular complications of intravesical BCG treatment for bladder carcinoma. Br J Urol 1992;70:446–447.PubMedGoogle Scholar
  103. 103.
    Kristjansson M, Green P, Manning HL, Slutsky AM, Brecher SM, Fordham von Reyn C, Arbeit RD, Maslow JN. Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract installation. Clin Infect Dis 1993:17:228–230.PubMedGoogle Scholar
  104. 104.
    Jawad ASM, Kahn L, Copland RFP, Henderson DC, Abdul-Ahad AK. Reactive arthritis associated with bacillus Calmette-Guérin immunothcrapy for carcinoma of the bladder: A report of two cases. Br J Rheumatol 1993:32:1018–1020.PubMedCrossRefGoogle Scholar
  105. 105.
    Pancaldi P, VanLinthoudt D, Alborino D, Haefliger JM, Ott H. Reiter’s syndrome after intravesical bacillus Calmette-Guérin treatment for superficial bladder carcinoma. Br J Rheumatol 1993:32:1096–1098.PubMedCrossRefGoogle Scholar
  106. 106.
    Ariyan S. Infections following surgery for head and neck cancer. Clin Plast Surg 1979;6:523–535.PubMedGoogle Scholar
  107. 107.
    Curtis TA, Griffith MR, Firtell DN. Complete denture prosthodontics for the radiation patient. J Prosthet Dent 1976:36:66–76.PubMedCrossRefGoogle Scholar
  108. 108.
    Brown LR, Dreizen S, Handler S, Johnston DA. Effect of radiation-induced xerostomia on human oral microfiora. J Dent Res 1975:54:740–750.PubMedGoogle Scholar
  109. 109.
    Dreizen S, Brown LR, Handler S, Levy BM. Radiation-induced xerostomia in cancer patients: Effect on salivary and serum electrolytes. Cancer 1976;38:273–278.PubMedCrossRefGoogle Scholar
  110. 110.
    Martin MV, Al-Tikriti U, Bramley PA. Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer. J Med Microbiol 1981:14:457–467.PubMedGoogle Scholar
  111. 111.
    Bartlett JG, Gorbach SL. Anaerobic infections of the head and neck. Otolarygol Clin North 1976:9:655–678.Google Scholar
  112. 112.
    Sawyer R. Clinical implications of metronidazole antianaerobic prophylaxis in major head and neck surgical procedures. Ear Nose Throat J 1988;67:655–662.PubMedGoogle Scholar
  113. 113.
    Robbins KT, Byers RM, Cole R. Fainstein V, Guillamondegui OM, Schantz SP, Weber RS, Wolf P, Goepfert H. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 1988:98:803–806.PubMedCrossRefGoogle Scholar
  114. 114.
    Brook I, Hirokawa R. Microbiology of wound infection after head and neck cancer surgery. Ann Otol Rhinol Laryngol 1989:98:323–325.PubMedGoogle Scholar
  115. 115.
    Coleman JJ. Complications in head and neck surgery. Surg Gin North Am 1986;66:149–167.Google Scholar
  116. 116.
    Tandon DA, Bahadur S, Laldina HC, Sundaram KR. Role of prophylactic antibiotics in surgery for advanced head and neck cancer. J Laryngol Otol 1992;106:621–624.PubMedGoogle Scholar
  117. 117.
    Robbins KT, Favrot S, Hanna D, Cole R. Risk of wound infection in patients with head and neck cancer. Head Neck 1990:12:143–148.PubMedCrossRefGoogle Scholar
  118. 118.
    Brown BM, Johnson JT, Wagner RL. Etiologic factors in head and neck wound infections. Laryngoscope 1987:97:587–590.PubMedGoogle Scholar
  119. 119.
    Hussain M. Kish JA, Crane L, Uwayda A. Cummings G, Ensley JF, Tapazoglou E, Al-Sarraf M. The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodal therapy. Cancer 1991:67:716–721.PubMedCrossRefGoogle Scholar
  120. 120.
    Papac RJ. Medical aspects of head and neck cancer. Cancer Invest 1985:3:435–444.PubMedCrossRefGoogle Scholar
  121. 121.
    Weber RS, Hankins P, Rosenbaum B. Rand I. Nonwound infections following head and neck oncologic surgery. Laryngoscope 1993:103:22–27.PubMedGoogle Scholar
  122. 122.
    Jansma J, Vissink A, Spijkervet FKL, Roodenburg JLN, Panders AK, Vermey A, Szabo BG, Johannes’s-Gravenmade E. Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 1992;70:2171–2180.PubMedCrossRefGoogle Scholar
  123. 123.
    Barber GR, Miransky J, Brown AE. Coit DG, Lewis FM, Thaler HT, Kiehn TE, Armstrong D. Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 1995; 130:1042–1047.PubMedGoogle Scholar
  124. 124.
    Dillman RO, Herndon J, Seagren SL, Eaton WL, Green MR. Improved survival in stage III non-small-cell lung cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996:88:1210–1215.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1998

Authors and Affiliations

  • Sarah H. Sutton
  • John P. Flaherty

There are no affiliations available

Personalised recommendations